Dr Biz Boom Opens Its Doors in Clearwater, Florida
February 14, 2022 13:28 ET
|
Dr. Biz Boom
CLEARWATER, Fla., Feb. 14, 2022 (GLOBE NEWSWIRE) -- After watching her Father suffer for years with Neuropathy while hearing countless Doctors say there was nothing they could do except give him...
Broadway Vascular Opens New Vascular Clinic in San Antonio
October 19, 2021 09:00 ET
|
Broadway Vascular
SAN ANTONIO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Broadway Vascular is the new vascular specialist in San Antonio focused on minimally invasive, non-surgical procedures to keep patients out of the...
NeuroMetrix Reports that Quell® Technology is to be Evaluated for Neuromyelitis Optica Spectrum Disorder (NMOSD) in a Randomized Controlled Trial
June 15, 2021 09:00 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., June 15, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that Quell technology will be used in a double-blinded, randomized, sham-controlled trial to...
NeuroMetrix Reports Q1 2021 Financial Results
April 22, 2021 07:00 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2021. The Company is a leader in...
NeuroMetrix Reports Publication of Study Validating DPNCheck® Staging of Diabetic Peripheral Neuropathy Severity
September 01, 2020 13:00 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., Sept. 01, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported the publication of a large study demonstrating that DPNCheck effectively determines the severity of...
UPDATE: ECOFIBRE LIMITED – Ananda Health products used in first clinical trial on hemp-derived CBD to treat chemotherapy-induced peripheral neuropathy
July 23, 2020 08:00 ET
|
Ecofibre
Georgetown, Kentucky, July 23, 2020 (GLOBE NEWSWIRE) -- Ecofibre Limited (Ecofibre, Company) (ASX:EOF, OTC-NASDAQ Intl Designation: EOFBF) is pleased to announce that the Lankenau Institute for...
ECOFIBRE LIMITED – Ananda Health products used in first FDA authorized clinical trial on hemp-derived CBD to treat chemotherapy induced peripheral neuropathy
July 07, 2020 08:58 ET
|
Ecofibre
Georgetown, Kentucky, July 07, 2020 (GLOBE NEWSWIRE) -- Ecofibre Limited (Ecofibre, Company) (ASX:EOF, OTC-NASDAQ Intl Designation: EOFBF) is pleased to announce that the Lankenau Institute for...
Aptinyx Reports Second Quarter 2019 Financial Results and Highlights
August 12, 2019 06:33 ET
|
Aptinyx Inc.
Reported that NYX-2925 met primary and secondary endpoints in Phase 2 fibromyalgia study On track to initiate three additional Phase 2 studies in 2H 2019 across pipeline of CNS product candidates ...
AngioSoma Launches E-Commerce Website
April 15, 2019 09:30 ET
|
AngioSoma, Inc.
HOUSTON, TX, April 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma, Inc. (OTC: SOAN), a leading developer of dietary supplements and biotechnology research and development company, is...
PledPharma presents PledOx®’s phase III program at the Gastrointestinal (GI) Cancers Symposium
January 17, 2019 02:00 ET
|
PledPharma AB
Stockholm, January 17, 2019. PledPharma AB (publ) announces that the company’s global phase III program, POLAR, has been accepted for a poster presentation during the Gastrointestinal (GI) Cancers...